United States · FDA National Drug Code directory

Coxs Homo

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 43742-1794_c078614a-40a7-43dc-bfa8-9b23d4fd4268
Product NDC: 43742-1794
Form: LIQUID
Composition / generic term: Coxsackie Nosode A2, Coxsackie Nosode B1, Coxsackie Nosode B3, Coxsackie Nosode B4, Coxsackie Nosode A7
Labeler: Deseret Biologicals, Inc.
Marketing category: UNAPPROVED HOMEOPATHIC
Marketing start / end (source format): 20200923
Source listing expiry: 20261231

Source-listed ingredients

HUMAN COXSACKIEVIRUS A2 — 15 [hp_C]/mL
HUMAN COXSACKIEVIRUS B1 — 15 [hp_C]/mL
HUMAN COXSACKIEVIRUS B3 — 15 [hp_C]/mL
HUMAN COXSACKIEVIRUS B4 — 30 [hp_C]/mL
HUMAN COXSACKIEVIRUS A7 — 45 [hp_C]/mL

These values do not establish equivalence or a dose recommendation.

Packages

30 mL in 1 BOTTLE, DROPPER (43742-1794-1) · 43742-1794-1

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →